CDNA

MKT CAP:$1B

CareDx Inc

Market Cap

$1B

Healthcare·Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Diagnostics·🇺🇸·NASDAQ

Stock Price

$22.25+$3.11 (+16.25%)

Jun 5, 2026

52W High $23.1252W Low $11.57

Company Details

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for ...

CEO

—

IPO Date

Jul 17, 2014

Website

caredx.com

Key Metrics TTM

Revenue

$413M

+19.2% YoY

Net Income

-$8M

EPS (Diluted)

Free Cash Flow

$65M

Revenue / Share

$7.77

Gross Margin

68.6%

Operating Margin

-3.2%

Net Margin

-2.0%

FCF Margin

15.8%

P/S

2.9x

P/E

Earnings Reports

Q2 2026

Aug 5, 2026

PENDING

Q1 2026

Apr 28, 2026

$118M+39.0%

FY 2025

Feb 25, 2026

$380M+13.8%

Q4 2025

Feb 25, 2026

$108M+25.2%

Q3 2025

Nov 4, 2025

$100M+20.7%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee